share_log

HC Wainwright & Co. Maintains Buy on Context Therapeutics, Lowers Price Target to $4

Moomoo 24/7 ·  Mar 21 12:21

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and lowers the price target from $5 to $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment